Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
X
X
Scientific presentation

Precision over bulk


Koichi Takahashi, MD
Dennis Eastburn, PhD
Jerry Radich, MD

Nature (2017)
Description

Fifty percent (50%) of patients with acute myeloid leukemia (AML) relapse and develop a more virulent form of the disease. To better understand AML and the cancer ecosystem, it is necessary to discern clonal architecture and the dynamics of competing clones, which provide valuable insight into therapy response. It takes three or more mutations for leukemia to form. This can occur in the same cell or within the tumor microenvironment, but how do you discern this information with bulk sequencing? Dr. Jerry Radich, of Stanford Medical Center, and Dr. Koichi Takahashi, of MD Anderson, share their research on how they were able to identify mutations within rare subclones using single-cell analysis for precision over bulk sequencing.



VIEW


Scientific presentation
Get SNVs and CNVs from the Tapestri Platform
Kelly Kaihara, PhD
Robert Durruthy-Durruthy, PhD
Nature Research (2019)
Scientific presentation
Investigation of AML clonal architecture with mutational and immunophenotypic profiling simultaneously from the same cell(s)
Linde Miles, PhD
AMP (2019)
Scientific presentation
In pursuit of the leukemic stem cell: Leveraging single-cell genomics and proteomics to identify drivers of AML
Katherine D Cummins, MD FRACP FRCPA
AMP (2019)
Scientific presentation
Single-cell sequencing reveals clonal heterogeneity in acute lymphoblastic leukemia
Jan Cools, PhD
Llucia Albert Servera, PhD
Nature Research (2019)
REQUEST QUOTE